Insider trades
David P. Schenkein, Director of Prime Medicine PRME, has filed 0 purchases and 16 sales on the open market. The latest trade was on 06/05.
David P. Schenkein
Director
- Company
- Prime Medicine PRME
- First filing
- 23/03/29
- Trades
- 72 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- No record
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
DNLI | Open-market sale10b5-1 plan | 24/11/11 | 24/11/13 | 59,441 sh2 trades | $32.51avg. | $1,932,665.05 | −86.6% |
AGIO | Open-market sale | 24/02/27 | 24/02/29 | 69,329 sh2 trades | $34.67avg. | $2,403,591.99 | −36.1% |
AGIO | Open-market sale | 24/02/23–24/02/26 | 24/02/27 | 68,142 sh2 trades | $33.09avg. | $2,254,950.64 | −35.7% |
| Open-market sale10b5-1 plan | 23/04/03 | 23/04/05 | 16,363 sh | $22.85 | $373,894.55 | −12.2% | |
| Open-market sale10b5-1 plan | 23/03/27 | 23/03/29 | 20,000 sh | $22.15 | $443,000 | −14.5% | |
AGIO | Open-market sale | 23/03/13 | 23/03/15 | 20,000 sh2 trades | $22.49avg. | $449,816.75 | −14.5% |
| Open-market sale | 23/02/27 | 23/03/01 | 20,000 sh | $25.37 | $507,400 | −14.5% | |
| Open-market sale | 23/02/13 | 23/02/15 | 20,000 sh | $28.62 | $572,400 | −14.5% | |
AGIO | Open-market sale | 23/01/30 | 23/02/01 | 20,000 sh2 trades | $29.33avg. | $586,578 | −14.5% |
AGIO | Open-market sale | 23/01/17 | 23/01/19 | 20,000 sh2 trades | $28.85avg. | $577,092.78 | −14.5% |
